KR20190071484A - Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles - Google Patents

Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles Download PDF

Info

Publication number
KR20190071484A
KR20190071484A KR1020170172570A KR20170172570A KR20190071484A KR 20190071484 A KR20190071484 A KR 20190071484A KR 1020170172570 A KR1020170172570 A KR 1020170172570A KR 20170172570 A KR20170172570 A KR 20170172570A KR 20190071484 A KR20190071484 A KR 20190071484A
Authority
KR
South Korea
Prior art keywords
chitosan
chitosan nanoparticles
nanoparticles
present
aqueous
Prior art date
Application number
KR1020170172570A
Other languages
Korean (ko)
Inventor
송재용
홍성원
Original Assignee
송재용
홍성원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 송재용, 홍성원 filed Critical 송재용
Priority to KR1020170172570A priority Critical patent/KR20190071484A/en
Publication of KR20190071484A publication Critical patent/KR20190071484A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The present invention relates to a method of preparing chitosan nanoparticles, and a functional cosmetic composition comprising the chitosan nanoparticles and reducing fine dusts or chemicals on the skin. The method of preparing chitosan nanoparticles comprises the following steps: (a) dissolving chitosan in an aqueous organic acid solution; (b) adding an aqueous sodium pyrophosphate solution to the aqueous chitosan solution prepared in step (a); and (c) removing the supernatant from the aqueous solution prepared in step (b) by centrifugation, and freeze-drying the same. The method of the present invention enables production of chitosan nanoparticles in a more stable form by an extremely simple process. Further, the chitosan nanoparticles of the present invention can significantly reduce the fine dusts or chemicals on the skin, and thus may be used as a functional cosmetic composition.

Description

키토산 나노입자의 제조방법 및 키토산 나노입자를 포함하는 오염물질 흡착 기능성 화장품 조성물{Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles}TECHNICAL FIELD [0001] The present invention relates to a method for preparing chitosan nanoparticles, and a cosmetic composition for adsorbing pollutants including chitosan nanoparticles,

본 발명은 키토산 나노입자의 제조방법 및 이 방법에 의해 제조된 키토산 나노입자를 포함하는 미세먼지 또는 화학물질을 감소시키는 기능성 화장품 조성물에 관한 것이다.The present invention relates to a process for producing chitosan nanoparticles and functional cosmetic compositions for reducing fine dust or chemicals containing chitosan nanoparticles prepared by the process.

키토산은 글루코오스아민(glucosamine)의 피라노스(pyranose) 단위체가 β-1,4 결합된 것으로서, 글루코오스아민 잔기가 5,000 개 이상 결합된 분자량이 100만 이상이고 다가의 양이온을 가진 다당류(polysaccharide) 계열의 생체고분자물질로 게 껍질이나 새우와 같은 갑각류 및 오징어를 포함하는 수산계로부터 추출할 수 있으며, 그 분자 구조로 볼 때 다당류의 일종인 셀룰로오스와 유사한 구조로서, 생체 친화성이 우수하여 면역 반응 시 거부 반응이 일어나지 않기 때문에 의약 산업에 응용되고 있고, 최근 미국의 FDA에서 식품으로서 인증을 받은 후, 키토산은 21세기의 중요한 생물산업 및 생체의료용 물질로 응용되고 있다. 특히, 20,000 ∼ 100,000 이내의 특정 분자량의 범위를 가진 키토산은 강한 생리활성 기능을 띠고 있는 것으로 알려져 있기 때문에 건강 식품분야, 식ㆍ음료 분야, 화장품 분야, 보건위생 분야 및 의약품 분야에 대한 응용성을 기대할 수 있다.Chitosan is a β-1,4-linked pyranose unit of glucosamine. The chitosan has a molecular weight of more than 5,000 and has a polysaccharide family of multivalent cations. Biomolecules can be extracted from fisheries including crustaceans such as crab shells and shrimp, and squid. In terms of its molecular structure, it has a structure similar to cellulose, which is a type of polysaccharide. It has excellent biocompatibility, Has been applied to the pharmaceutical industry since it does not occur. Recently, after being certified as a food by the US FDA, chitosan has been applied as an important biological industry and biomedical materials in the 21st century. In particular, chitosan having a specific molecular weight within a range of 20,000 to 100,000 is known to have a strong physiological activity, so it is expected to be applicable to the fields of health food, food and beverage, cosmetics, healthcare and pharmaceuticals .

또한, 키토산(chitosan)은 인슐린과 같은 약물의 장내 상피세포를 통한 흡수촉진 효과가 있음이 알려져 있다(Artursson, P., Lindmark, T., Davis, S.S., Illum, L., 1994. “Effect of chitosan on the permeability of monolayer of intestinal epithelial cells (Caco-2)”, Pharm. Res. 11, 13581361). 특히 인슐린을 함유한 키토산 나노입자의 경구투여 시 인슐린의 체내 흡수율을 증가시켜 혈당을 감소시키는 연구결과가 보고되었다 (Pan, Y., Li, Y., Zhao, H., Zheng, J., Xu, H., Wei, G., Hao, J., Cui, F., 2002, “Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo”, Int. J. Pharm. 249, 13147).In addition, chitosan has been known to have the effect of stimulating absorption through intestinal epithelial cells of drugs such as insulin (Artursson, P., Lindmark, T., Davis, SS, Illum, chitosan on the permeability of monolayer of intestinal epithelial cells (Caco-2) ", Pharm. Res. 11, 13581361). Li, Y., Zhao, H., Zheng, J., Xu, Y., < RTI ID = 0.0 > , H., Wei, G., Hao, J., Cui, F., 2002, "Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo", Int. J. Pharm. 249, 13147 ).

선행 문헌(J. Korean Fish. Soc. 32(3), 247~251, 1999) 에는 한외여과막 효소반응기를 이용하여 제조한 키토산 올리고당의 칼슘 흡수 촉진효과에 대해 개시되어 있으나 키토산 올리고 당의 제조방법이 매우 복잡하다. 또한, 선행 문헌(Journal of Applied Polymer Science, Vol. 63, 125-132, 1997) 에는 단백질 운반을 위한 친수성 키토산-폴리에틸렌 옥사이드 나노입자의 합성에 관해 설명되어 있으나, 칼슘 흡수 촉진과 같은 효과에 대해서는 개시되어 있지 않다.In the prior art (J. Korean Fish. Soc. 32 (3), 247-251, 1999), the calcium absorption promotion effect of chitosan oligosaccharides prepared using an ultrafiltration membrane enzyme reactor is disclosed, Complex. In addition, although the synthesis of hydrophilic chitosan-polyethylene oxide nanoparticles for protein transport has been described in the prior art (Journal of Applied Polymer Science, Vol. 63, 125-132, 1997) .

한편, 대한민국 등록특허 제10-0661125호는 키토산 미립자 및 이의 제조방법에 대해 개시하고 있는데, 이 특허문헌에서는 고체 키토산을 용매에 용해시켜 키토산 용액을 제조하고 여기에 황산기를 함유한 계면활성제를 첨가하여 나노크기의 미립자를 형성한 후 이를 중화시켜 미세한 크기의 키토산 나노입자를 제조하는 방법에 대해 설명하고 있다. 그러나, 상기 특허문헌에서는 키토산 나노입자 제조 시에 인체에 유해한 황산기 함유 계면활성제를 사용함으로써 식품 조성물등에 사용하기에는 적합하지 않다.On the other hand, Korean Patent No. 10-0661125 discloses chitosan microparticles and a method for producing the chitosan microparticles. In this patent document, a chitosan solution is prepared by dissolving solid chitosan in a solvent, adding thereto a surfactant containing a sulfate group A method of forming nano-sized fine particles and then neutralizing them to prepare fine-sized chitosan nanoparticles is described. However, in the above patent documents, it is not suitable for use in food compositions or the like by using a sulfate group-containing surfactant which is harmful to the human body when producing chitosan nanoparticles.

본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다.Numerous papers and patent documents are referenced and cited throughout this specification. The disclosures of the cited papers and patent documents are incorporated herein by reference in their entirety to better understand the state of the art to which the present invention pertains and the content of the present invention.

본 발명자들은 키토산의 나노입자를 인체에 유해한 계면활성제를 사용하지 않고 간단한 공정을 통해 제조할 수 있는 방법을 찾기 위해 연구한 결과, 종래부터 식품첨가제로 사용하고 있는 인체에 무해한 피로인산염(sodium pyrophosphate)를 겔화제(gelling agent)로 사용하여 키토산의 나노입자를 제조할 수 있음을 확인하였다. 또한, 이렇게 제조한 키토산 나노입자를 피부의 미세먼지 또는 화학물질을 현저히 감소시키는 기능성 화장품 조성물로 사용할 수 있음을 확인함으로써 본 발명을 완성하였다.The present inventors have studied to find a method for producing nanoparticles of chitosan through a simple process without using a surfactant detrimental to the human body. As a result, it has been found that sodium pyrophosphate, which is conventionally used as a food additive and harmless to humans, Was used as a gelling agent to prepare nanoparticles of chitosan. Further, the present inventors have completed the present invention by confirming that the chitosan nanoparticles thus prepared can be used as functional cosmetic compositions for significantly reducing fine dust or chemical substances in the skin.

따라서, 본 발명의 목적은 키토산 나노입자를 제조하는 방법을 제공하는 것에 있다.Accordingly, an object of the present invention is to provide a method for producing chitosan nanoparticles.

본 발명의 다른 목적은 키토산 나노입자 및 피부의 미세먼지 또는 화학물질을 현저히 감소시키므로 기능성 화장품 조성물을 제공하는 것에 있다.Another object of the present invention is to provide a functional cosmetic composition because it significantly reduces chitosan nanoparticles and fine dust or chemicals in the skin.

본 발명의 목적 및 장점은 하기의 발명의 상세한 설명, 청구의 범위 및 도면에 의해 보다 명확하게 된다.The objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.

본 발명의 일 양태에 따르면, 본 발명은 다음의 단계를 포함하는 키토산 나노입자(chitosan nanoparticle)의 제조방법을 제공한다: (a) 키토산(chitosan)을 유기산(organic acid) 수용액에 용해시키는 단계; (b) 상기 단계 (a)에서 제조한 키토산 수용액에 피로인산염(sodium pyrophosphate) 수용액을 첨가하는 단계; 및 (c) 상기 단계 (b)에서 제조한 수용액을 원심분리하여 상등액을 제거한 후 동결건조하는 단계.According to one aspect of the present invention, there is provided a process for preparing a chitosan nanoparticle comprising the steps of: (a) dissolving chitosan in an aqueous solution of an organic acid; (b) adding an aqueous solution of sodium pyrophosphate to the aqueous chitosan solution prepared in step (a); And (c) centrifuging the aqueous solution prepared in step (b) to remove the supernatant and freeze-drying the supernatant.

본 발명자들은 키토산의 나노입자를 인체에 유해한 계면활성제를 사용하지 않고 간단한 공정을 통해 제조할 수 있는 방법을 찾기 위해 연구한 결과, 종래부터 식품첨가제로 사용하고 있는 인체에 무해한 피로인산염(sodium pyrophosphate)를 겔화제(gelling agent)로 사용하여 키토산의 나노입자를 제조할 수 있음을 확인하였다.The present inventors have studied to find a method for producing nanoparticles of chitosan through a simple process without using a surfactant detrimental to the human body. As a result, it has been found that sodium pyrophosphate, which is conventionally used as a food additive and harmless to humans, Was used as a gelling agent to prepare nanoparticles of chitosan.

이하 각 단계에 따라 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the respective steps.

단계 (a): 키토산(chitosan)을 유기산(organic acid) 수용액에 용해시키는 단계 Step (a): dissolving chitosan in an aqueous solution of an organic acid

본 발명에서 키토산 나노입자의 제조에 사용된 키토산은 특별히 한정되지 않으나, 바람직하게는 분말 형태이고 점도 10 cps이고, 탈아세탈화도가 80% 이상인 키토산을 사용한다.The chitosan used in the production of chitosan nanoparticles in the present invention is not particularly limited, but chitosan having a viscosity of 10 cps and a deacetylation degree of 80% or more is preferably used in powder form.

불용성의 키토산을 용해시키기 위해 키토산을 유기산(organic acid) 수용액에 용해시켜 키토산의 수용액을 제조한다. 바람직하게는 상기 유기산(organic acid)은 젖산(lactic acid), 초산(acetic acid), 프로피온산(propionic acid), 포름산(formic acid), 아스코르브산(ascorbic acid) 및 주석산(tartaric acid)을 포함하나, 이에 한정되지 않는다. 가장 바람직하게는 상기 유기산은 초산(acetic acid)이다.To dissolve insoluble chitosan, an aqueous solution of chitosan is prepared by dissolving chitosan in an aqueous solution of organic acid. Preferably, the organic acid is selected from the group consisting of lactic acid, acetic acid, propionic acid, formic acid, ascorbic acid and tartaric acid, But is not limited thereto. Most preferably, the organic acid is acetic acid.

키토산 수용액에서 키토산의 농도는 특정 범위로 한정되지 않으나, 바람직하게는 0.1-0.5%(W/V)가 되도록한다.The concentration of chitosan in the aqueous solution of chitosan is not limited to a specific range, but is preferably 0.1-0.5% (W / V).

단계 (b): 상기 단계 (a)에서 제조한 키토산 수용액에 피로인산염(sodium pyrophosphate) 수용액을 첨가하는 단계 Step (b): adding an aqueous solution of sodium pyrophosphate to the aqueous chitosan solution prepared in step (a)

본 발명의 제조방법에서 겔화제(gelling agent)로서 피로인산염(sodium pyrophosphate)를 사용하는 것에 기술적 특징이 있다. 피로인산염는 본 발명의 키토산 수용액에서 키토산의 겔화 반응을 촉진하는 겔화제로 작용한다. 피로인산은 하기와 같은 화학식의 나트륨 염(sodium salt)의 형태로 존재하는 화합물이다.In the production process of the present invention, there is a technical feature to use sodium pyrophosphate as a gelling agent. The pyrophosphate acts as a gelling agent for promoting the gelation reaction of chitosan in the aqueous chitosan solution of the present invention. Pyrophosphoric acid is a compound that exists in the form of a sodium salt of the formula:

Figure pat00001
Figure pat00001

피로인산염(sodium pyrophosphate)는 종래부터 해산식품(sea food), 육류식품, 가금류식품 및 애완동물용 식품의 식품보존료 등의 다양한 용도로 사용되어 왔고, 미국식품의약국(United States Food and Drug Administration)은 피로인산염(sodium pyrophosphate)를 인체에 안전한 화합물로 인정하고 있다.Sodium pyrophosphate has traditionally been used in a variety of applications including sea food, meat, poultry, and food preservatives for pets, and the United States Food and Drug Administration Has recognized sodium pyrophosphate as a safe compound in the human body.

단계 (c) : 상기 단계 (b)에서 제조한 수용액을 원심분리하여 상등액을 제거한 후 동결건조하는 단계 Step (c): The aqueous solution prepared in the step (b) is centrifuged to remove the supernatant, followed by lyophilization

상기 피로인산염(sodium pyrophosphate) 수용액이 첨가된 키토산 수용액을 잘 혼합되도록 교반한다. 교반 시 조건은 특별하게 한정되지 않으나 본 발명의 구체적인 일 실시예에 의하면, 37℃, 300 rpm에서 30분간 교반한다. 원심분리는 통상적인 원심분기기를 이용하여 행하며 15,000 rpm에서 30분 정도 원심분리를 행한다. 원심분리한 후에 상등액을 제거한 후 동결건조함으로써 키토산 나노입자의 분말을 제조한다.The aqueous chitosan solution to which the aqueous solution of sodium pyrophosphate is added is stirred to be well mixed. Conditions for stirring are not particularly limited, but according to one specific embodiment of the present invention, the mixture is stirred at 37 DEG C and 300 rpm for 30 minutes. Centrifugation is carried out using a conventional centrifugal separator and centrifugation is carried out at 15,000 rpm for 30 minutes. After centrifugation, the supernatant is removed and lyophilized to prepare chitosan nanoparticle powder.

본 발명의 다른 양태에 따르면, 본 발명은 상기 방법에 의해 제조된 키토산 나노입자를 제공한다. 본 발명의 방법에 의해 제조된 키토산 나노입자는 입자의 크기가 20 nm - 1 ㎛으로서, 식품, 음료, 의약품 및 화장품 등의 제조시 첨가제로 사용될 수 있다.According to another aspect of the present invention, there is provided a chitosan nanoparticle produced by the above method. The chitosan nanoparticles prepared by the method of the present invention have a particle size of 20 nm - 1 탆 and can be used as an additive in the production of foods, beverages, medicines and cosmetics.

본 발명의 또 다른 양태에 따르면, 본 발명은 (a) 상기 방법에 의해 제조된 키토산 나노입자; 및 (b) 피부의 중금속, 미세먼지 또는 화학물질을 현저히 감소시키므로 기능성 화장품 조성물을 제공한다.According to still another aspect of the present invention, there is provided a method of producing a chitosan nanoparticle comprising: (a) preparing chitosan nanoparticles by the method; And (b) significantly reduces the heavy metals, fine dusts, or chemicals of the skin, thereby providing a functional cosmetic composition.

본 발명자들은 본 발명의 방법에 의해 제조된 키토산 나노입자를 피부의 중금속, 미세먼지 또는 화학물질을 현저히 감소시킬 수 있음을 발견하였다. 이러한 효과는 본 발명의 키토산 나노입자에 존재하는 아미노기와 카르복실기가 중금속 또는 화학물질과 킬레이트결합 또는 이온결합 함으로써 피부를 세정 할 경우 오염물질 탈착을 촉진하는 메카니즘에 의해 발생하는 것으로 추정된다.The present inventors have found that chitosan nanoparticles prepared by the method of the present invention can significantly reduce heavy metals, fine dusts, or chemicals in the skin. This effect is presumed to be caused by a mechanism for promoting desorption of contaminants when the skin is cleaned by chelate bonding or ionic bonding with amino groups and carboxyl groups present in the chitosan nanoparticles of the present invention with heavy metals or chemicals.

본 발명의 바람직한 구현예에 의하면, 상기 본 발명의 기능성 화장품 조성물에 포함되는 키토산 나노입자의 농도는 0.05-5 중량%인 것을 특징으로 한다. 키토산 나노입자의 농도가 0.05 중량% 미만인 경우에는 중금속 또는 오염물질 흡착 촉진 효과가 미약하게 나타나며, 키토산 나노입자가 5 중량%를 초과하여 포함되는 경우에는 첨가되는 키토산 나노입자의 양에 비하여 증진된 중금속 또는 오염물질 흡착의 촉진 효과를 얻기 어려워 경제적이지 못하다.According to a preferred embodiment of the present invention, the concentration of the chitosan nanoparticles contained in the functional cosmetic composition of the present invention is 0.05-5 wt%. When the concentration of the chitosan nanoparticles is less than 0.05 wt%, the effect of promoting the adsorption of heavy metals or contaminants is weak. When the chitosan nanoparticles are contained in an amount exceeding 5 wt%, the amount of the heavy metal Or the promoting effect of adsorbing contaminants is difficult to obtain, which is not economical.

본 발명의 기능성 화장품 조성물은 화장품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어,정제조, 클리세린, 나이아신아마이드, 디프로필렌글라이콜, 알란토인, 아데노신, 향료, 디소듐이디티에이, 페녹시에타올 및 클로페네신를 포함한다.The functional cosmetic composition of the present invention includes components that are ordinarily added in the course of the manufacture of cosmetics and includes, for example, tablets, tablets, , Phenoxyethanol, and chlorphenesin.

본 발명의 바람직한 구현예에 의하면, 본 발명의 상기 기능성 화장품 조성물의 형태는 건조 분말 형태, 크림 형태, 젤리 형태, 세럼 형태, 에센스 형태 또는 마스크팩 형태를 포함하나, 이에 한정되지 않는다.According to a preferred embodiment of the present invention, the form of the functional cosmetic composition of the present invention includes, but is not limited to, a dry powder form, a cream form, a jelly form, a serum form, an essence form or a mask pack form.

본 발명의 키토산 나노입자의 제조방법에 의하면, 인체에 무해한 것으로 종래부터 식품첨가제로 사용되어 오던 피로인산염(sodium pyrophosphate)를 겔화제(gelling agent)로 이용함으로써 보다 안전한 형태의 키토산 나노입자를 제조할 수 있다. 또한, 본 발명의 제조방법에 의하면 간단한 방법으로 키토산 나노입자를 제조할 수 있어 매우 경제적이다. 본 발명의 방법에 의해 제조된 키토산 나노입자를 기능성 화장품 조성물을 제조하면 키토산 나노입자가 중금속 또는 화학물질과 결합하여 안정한 형태로 유도함으로써 피부 세정 시 오염물질을 현저하게 제거시키는 효과가 있다.According to the method for producing chitosan nanoparticles of the present invention, safer form of chitosan nanoparticles can be prepared by using sodium pyrophosphate, which has been conventionally used as a food additive, as a gelling agent, which is harmless to the human body . Further, according to the production method of the present invention, chitosan nanoparticles can be produced by a simple method, which is very economical. When the functional cosmetic composition is prepared from the chitosan nanoparticles produced by the method of the present invention, the chitosan nanoparticles combine with heavy metals or chemical substances to induce the chitosan nanoparticles to have a stable form, thereby remarkably eliminating contaminants during skin cleansing.

도 1에는 본 발명의 방법에 의해 제조한 키토산 나노입자의 크기 분포도를 Zetasizer Nano 분석기(Malvern 사)로 측정한 결과를 나타내었다. 이 결과에 의하면, 키토산 나노입자의 평균 입자 크기는 151 nm인 것을 알 수 있다.
도 2는 본 발명의 방법에 의해 제조한 키토산 나노입자의 SEM(Scanning electron Microscopy)을 이용하여 분석한 결과를 보여준다.
FIG. 1 shows the results of measurement of the size distribution of chitosan nanoparticles prepared by the method of the present invention with a Zetasizer Nano analyzer (Malvern). According to these results, the average particle size of the chitosan nanoparticles is 151 nm.
FIG. 2 shows the results of SEM (Scanning Electron Microscopy) analysis of chitosan nanoparticles prepared by the method of the present invention.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .

키토산 에멀젼 수용액의 준비Preparation of Chitosan Emulsion Aqueous Solution

본 발명에서 사용한 키토산은 (주)키토라이프 키토산 분말을 구매하여 사용하으며, 점도 10 cps, 탈아세틸화도 80% 이상인 키토산을 사용하였다. 상기 키토산을 5% 초산(acetic acid) 수용액에 0.1-0.5%(w/v)가 되도록 37℃에서 1시간 교반하여 용해시켰다.The chitosan used in the present invention was chitosan powder having a viscosity of 10 cps and a deacetylation degree of 80% or more by using chitosan chitosan powder. The chitosan was dissolved in 5% acetic acid aqueous solution at 37 ° C for 1 hour with stirring to 0.1-0.5% (w / v).

키토산 나노입자의 제조 Preparation of chitosan nanoparticles

상기와 같이 제조한 키토산 수용액에 0.05%(w/v)의 피로인산염(sodium pyrophosphate) 수용액을 서서히 첨가시켜, 37℃에서 300 rpm으로 30 분간 교반하여 혼합하였다. 이어서, 원심분리기를 이용 15,000 rpm에서 30분 동안 원심분리한 후, 상등액을 제거하고 24시간 동안 동결건조하여 키토산 나노입자 분말을 제조하였다. 나노입자 크기 및 모양은 Malvern 사의 Zetasizer Nano 분석기와 SEM(Scanning electron Microscopy)을 이용하여 분석하였다.An aqueous 0.05% (w / v) sodium pyrophosphate solution was slowly added to the aqueous chitosan solution prepared above and stirred at 37 ° C for 30 minutes at 300 rpm. Subsequently, the mixture was centrifuged at 15,000 rpm for 30 minutes using a centrifuge, and the supernatant was removed and lyophilized for 24 hours to prepare chitosan nanoparticle powder. The size and shape of the nanoparticles were analyzed using Malvern Zetasizer Nano analyzer and SEM (Scanning electron Microscopy).

도 1에는 본 발명의 방법에 의해 제조한 키토산 나노입자의 크기 분포도를 Zetasizer Nano 분석기(Malvern 사)로 측정한 결과를 나타내었다. 이 결과에 의하면, 키토산 나노입자의 평균 입자 크기는 151 nm인 것을 알 수 있다.FIG. 1 shows the results of measurement of the size distribution of chitosan nanoparticles prepared by the method of the present invention with a Zetasizer Nano analyzer (Malvern). According to these results, the average particle size of the chitosan nanoparticles is 151 nm.

도 2는 본 발명의 방법에 의해 제조한 키토산 나노입자의 SEM(Scanning electron Microscopy)을 이용하여 분석한 결과를 보여준다.FIG. 2 shows the results of SEM (Scanning Electron Microscopy) analysis of chitosan nanoparticles prepared by the method of the present invention.

키토산 나노입자의 납결합능 측정Measurement of lead binding ability of chitosan nanoparticles

상기 방법으로 제조한 키토산 나노입자의 칼슘결합 성능을 측정하였다.The calcium binding performance of the chitosan nanoparticles prepared by the above method was measured.

포도 과즙 50 g에 본 발명의 방법으로 제조한 키토산 나노입자 분말을 0.1-0.5%(w/w) 되도록 첨가하여 18시간 교반시킨 후 원심분리하여 상등액을 취하여 ICP(Inductively Coupled Plasma Emission Spectroscopy)를 이용하여 납농도를 측정하였다. 측정 결과를 하기 [표 1]에 나타내었다.The chitosan nanoparticle powder prepared by the method of the present invention was added to the grape juice in an amount of 0.1-0.5% (w / w), and the mixture was stirred for 18 hours. The mixture was centrifuged and the supernatant was collected by ICP (Inductively Coupled Plasma Emission Spectroscopy) And the lead concentration was measured. The measurement results are shown in Table 1 below.

시료번호Sample number 첨가물의 구성 Composition of additives 납농도(ppm)Lead concentration (ppm) 납결합율(%)Lead Bonding Ratio (%) 00 납 수용액 50ml (대조군)Lead aqueous solution 50ml (control group) 78.478.4 -- 1One 납 수용액 50ml + 키토산 나노입자 0.1%(w/w)Lead aqueous solution 50 ml + Chitosan nanoparticles 0.1% (w / w) 68.868.8 12.512.5 22 납 수용액 50ml + 키토산 나노입자 0.3%(w/w)Lead aqueous solution + chitosan nanoparticle 0.3% (w / w) 65.465.4 16.216.2 33 납 수용액 50ml + 키토산 나노입자 0.5%(w/w)Lead aqueous solution + chitosan nanoparticle 0.5% (w / w) 61.161.1 22.122.1

상기 표 1의 결과로부터, 키토산 나노입자의 함유량이 증가할수록 납의 농도가 감소하고 납의 결합율이 증가함을 알 수 있다. 따라서,본 발명의 키토산 나노입자는 납과의 결합율을 증가시킴으로써 납을 안정하게 유지하여 피부로부터 탈착율을 향상시킬 수 있다.From the results in Table 1, it can be seen that as the content of chitosan nanoparticles increases, the concentration of lead decreases and the binding rate of lead increases. Accordingly, the chitosan nanoparticles of the present invention can increase the binding rate with lead, thereby stably maintaining the lead, thereby improving the desorption rate from the skin.

시료번호Sample number 첨가물의 구성 Composition of additives 카드늄농도(ppm)Cadmium concentration (ppm) 납카드늄
결합율(%)
Lead cadmium
Bonding rate (%)
00 카드늄 수용액 50ml (대조군)Cadmium aqueous solution 50ml (control group) 95.595.5 -- 1One 카드늄 수용액 50ml + 키토산 나노입자 0.1%(w/w)Cadmium aqueous solution 50 ml + chitosan nanoparticles 0.1% (w / w) 55.755.7 41.741.7 22 카드늄 수용액 50ml + 키토산 나노입자 0.3%(w/w)Cadmium aqueous solution 50 ml + chitosan nanoparticles 0.3% (w / w) 52.452.4 45.145.1 33 카드늄 수용액 50ml + 키토산 나노입자 0.5%(w/w)Cadmium aqueous solution 50 ml + chitosan nanoparticle 0.5% (w / w) 53.253.2 44.344.3

상기 표 2의 결과로부터, 키토산 나노입자의 함유량이 증가할수록 카드늄의 농도가 감소하고 카드늄의 결합율이 증가함을 알 수 있다. 따라서,본 발명의 키토산 나노입자는 카드늄과의 결합율을 증가시킴으로써 카드늄을 안정하게 유지하여 피부로부터 탈착율을 향상시킬 수 있다. From the results in Table 2, it can be seen that as the content of chitosan nanoparticles increases, the concentration of cadmium decreases and the binding ratio of cadmium increases. Accordingly, the chitosan nanoparticles of the present invention can increase the binding rate with cadmium, thereby stably maintaining cadmium, thereby improving the desorption rate from the skin.

이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.

Claims (5)

다음의 단계를 포함하는 키토산 나노입자의 제조방법:
(a) 키토산(chitosan)을 유기산(organic acid) 수용액에 용해시키는 단계;
(b) 상기 단계 (a)에서 제조한 키토산 수용액에 피로인산염(sodium pyrophosphate) 수용액을 첨가하는 단계; 및
(c) 상기 단계 (b)에서 제조한 수용액을 원심분리하여 상등액을 제거한 후, 동결건조하는 단계.
A method for producing chitosan nanoparticles comprising the steps of:
(a) dissolving chitosan in an aqueous solution of an organic acid;
(b) adding an aqueous solution of sodium pyrophosphate to the aqueous chitosan solution prepared in step (a); And
(c) centrifuging the aqueous solution prepared in the step (b) to remove the supernatant, followed by freeze-drying.
제 1 항에 있어서, 상기 유기산(organic acid)은 젖산(lactic acid), 초산(acetic acid), 프로피온산(propionic acid), 포름산(formic acid), 아스코르브산(ascorbic acid), 및 주석산(tartaric acid)으로 이루어지는 군에서 선택되는 것을 특징으로 하는 키토산 나노입자의 제조방법.The method of claim 1, wherein the organic acid is selected from the group consisting of lactic acid, acetic acid, propionic acid, formic acid, ascorbic acid, and tartaric acid. ≪ / RTI > wherein the chitosan nanoparticles are selected from the group consisting of: 제 1 항에 있어서, 상기 단계 (a)에서 제조한 키토산이 용해된 수용액의 키토산 농도는 0.1-0.5%(W/V)인 것을 특징으로 하는 키토산 나노입자의 제조방법.The method according to claim 1, wherein the aqueous chitosan solution prepared in step (a) has a chitosan concentration of 0.1-0.5% (W / V). 상기 제 1 항 내지 제 3 항 중 어느 한 항의 방법에 의해 제조된 키토산 나노입자로서, 입자의 크기가 20 nm - 1 ㎛인 것을 특징으로 하는 키토산 나노입자.A chitosan nanoparticle produced by the method according to any one of claims 1 to 3, wherein the chitosan nanoparticle has a particle size of 20 nm to 1 占 퐉. (a) 상기 제 1 항 내지 제 3 항 중 어느 한 항의 방법에 의해 제조된 키토산 나노입자; 및 (b) 피부의 중금속, 미세먼지 또는 화학물질을 현저히 감소시키는 기능성 화장품 조성물.(a) chitosan nanoparticles prepared by the method of any one of claims 1 to 3; And (b) a functional cosmetic composition that significantly reduces heavy metals, fine dust, or chemicals in the skin.
KR1020170172570A 2017-12-14 2017-12-14 Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles KR20190071484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170172570A KR20190071484A (en) 2017-12-14 2017-12-14 Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170172570A KR20190071484A (en) 2017-12-14 2017-12-14 Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles

Publications (1)

Publication Number Publication Date
KR20190071484A true KR20190071484A (en) 2019-06-24

Family

ID=67056292

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170172570A KR20190071484A (en) 2017-12-14 2017-12-14 Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles

Country Status (1)

Country Link
KR (1) KR20190071484A (en)

Similar Documents

Publication Publication Date Title
Xie et al. Structure, function and food applications of carboxymethylated polysaccharides: A comprehensive review
JP6007209B2 (en) Microparticle-soluble glucan preparation
EP2032180B1 (en) Glucan preparations
KR20200132584A (en) Stabilized astaxanthin nanoparticles and its manufacturing method
WO2016090873A1 (en) Nanocarrier and nanocomposite prepared by marine sulfated polysaccharide and application thereof
CN103524750A (en) Polyethylene glycol chitosan self-assembled nanoparticles and preparation method thereof
CN103251572B (en) Preparation method of theaflavin enteric microcapsule, as well as product prepared by preparation method and application of product
EP2776472A1 (en) Method for preparing glucans from aspergillus niger
CN113633781A (en) Astaxanthin-chitosan self-assembly nano compound and preparation method and application thereof
CN101721375B (en) Insulin slow release micron sphere composition and preparation method thereof
KR20190071484A (en) Method for Preparing Chitosan Nanoparticles and Functional cosmetics Composition for adsorption of pollutant Comprising the Chitosan Nanoparticles
CN112544982A (en) Nano-selenium pickering emulsion and preparation method and application thereof
CN114522150B (en) Preparation method and application of pH-sensitive plant microcapsule nano extruder
CN106890143A (en) The preparation method of the chitosan nano composite particles of appendix panaxoside and cordycepin
KR101094816B1 (en) Functional Food Composition for Improving Fruit Calcium Absorption Rate Comprising the Chitosan Nanoparticles
JP7249695B2 (en) Method for preparing water-soluble astaxanthin complex, method for preparing aqueous solution of astaxanthin, and method for preparing freeze-dried powder of astaxanthin
US20070265434A1 (en) Simplified method to retrieve chitosan from acidic solutions thereof
CN114106216A (en) Hyaluronic acid-astaxanthin nano-composite and preparation method and application thereof
CN110123805B (en) Preparation method of self-assembled procyanidine nano-composite
CN113244189A (en) Preparation method of ultra-small bionic nanoparticles based on erythrocyte membranes
KR20200056890A (en) Stabilizing of vitamin C derivatives and cosmetic composition containing the same
CN112655873A (en) Solubilization method of high polymeric proanthocyanidins, compound prepared by solubilization method and application of compound
CN110772498A (en) Preparation method of novel fucoxanthin-loaded fucoidan sulfate nanoparticles
CN106924228B (en) Curcumin composition and preparation method and application thereof
JP2018140955A (en) Processed-thickening polysaccharides